Austin-based defense tech startup Saronic has secured $600 million in Series C funding to develop Port Alpha, an advanced factory for producing autonomous warships.
Augury, an industrial AI startup specializing in machine health monitoring, has secured $75 million in Series F funding, pushing its valuation past $1 billion.
As uncertainty looms over NIH funding, biotech leaders are stepping up with alternative financing solutions. Chris Gibson, co-founder and CEO of Recursion, along with serial biotech entrepreneur David Bearss, has launched the Altitude Lab Pre-seed Venture Fund, aimed at supporting early-stage biotech startups that typically rely on Small Business Innovation
BDC Capital, the venture arm of the Business Development Bank of Canada (BDC), has announced nearly $1 billion in new fund commitments aimed at late-stage Canadian tech companies.
Hightouch, a customer data platform (CDP) and AI-driven marketing automation startup, has secured $80 million in Series C funding, doubling its valuation to $1.2 billion.
Luminance, a UK-based legal AI startup, has raised $75 million in Series C funding to scale its AI-powered contract automation platform. The round was led by Point72 Private Investments, with participation from Forestay Capital, RPS Ventures, Schroders Capital, and existing investors March Capital, National Grid Partners, and Slaughter and May.
Level Zero Health, a UK- and US-based medtech startup, has secured $6.9 million in pre-seed funding to develop a wearable device for continuous hormone monitoring.
